Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 100.00% is 175% above its 5-year average of 36.36%, near the high end of its 5-year range (0.00%–100.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 50.00% above its 12-month average of 66.67%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 100.00%.
GROSS MARGIN
100.00%
GROSS MARGIN AVG TTM
66.67%
GROSS MARGIN AVG 3Y
57.14%
GROSS MARGIN AVG 5Y
36.36%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+50.00%
CURRENT VS 3Y AVG
+75.00%
CURRENT VS 5Y AVG
+175.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.82%
median of 729 covered companies
CURRENT VS SECTOR MEDIAN
+144.98%
vs the sector median at left
Connect Biopharma Holdings Limited
Market Cap
$60.88M
Gross Margin
100.00%
TTM Avg
66.67%
3Y Avg
57.14%
5Y Avg
36.36%
Market Cap
$60.12M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$60.10M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$58.29M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$63.19M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$58.57M
Gross Margin
0.00%
TTM Avg
23.12%
3Y Avg
20.52%
5Y Avg
13.68%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Connect Biopharma Holdings Limited (CNTB) | $60.88M | 100.00% | 66.67% | 57.14% | 36.36% |
| Adicet Bio, Inc. (ACET)vs › | $60.54M | 0.00% | 0.00% | 25.00% | 50.00% |
| PDS Biotechnology Corporation (PDSB)vs › | $60.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.10M | 0.00% | 0.00% | 0.00% | 0.00% |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.29M | 0.00% | 0.00% | 0.00% | 0.00% |
| InterCure Ltd. (INCR)vs › | $63.02M | 14.40% | 12.47% | 23.60% | 30.84% |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.19M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fractyl Health, Inc. (GUTS)vs › | $58.57M | 0.00% | 23.12% | 20.52% | 13.68% |
| Alps Group Inc (ALPS)vs › | $63.23M | 32.09% | 26.51% | 26.11% | 26.57% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | 0.00% | 0.00% | 50.00% | 66.67% |
Gross Margin
100.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 100.00% |
| 2025-12-31 | 0.00% |
| 2025-06-30 | 100.00% |
| 2024-12-31 | 100.00% |
| 2024-06-30 | 100.00% |
| 2023-12-31 | 0.00% |
| 2023-06-30 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-06-30 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-06-30 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-06-30 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-06-30 | 0.00% |
| 2018-12-31 | 0.00% |
